JunHe advised Biocytogen on the deal. Biocytogen Pharmaceuticals (Beijing) Co., Ltd. announced an antibody evaluation and option agreement with Gilead Sciences, Inc. The agreement provides Gilead access...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here